These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629 [TBL] [Abstract][Full Text] [Related]
26. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729 [TBL] [Abstract][Full Text] [Related]
27. Hypertrophic cardiomyopathy at 50. Yacoub M; Olivotto I; Cecchi F J Cardiovasc Transl Res; 2009 Dec; 2(4):339-40. PubMed ID: 20559992 [No Abstract] [Full Text] [Related]
32. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review]. Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001 [TBL] [Abstract][Full Text] [Related]
33. Sudden death and hypertrophic cardiomyopathy: a review. Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263 [TBL] [Abstract][Full Text] [Related]
34. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Boriani G; Maron BJ; Shen WK; Spirito P Circulation; 2004 Oct; 110(15):e438-42. PubMed ID: 15477422 [No Abstract] [Full Text] [Related]
35. ECGs in the ED. Tanel RE Pediatr Emerg Care; 2005 Nov; 21(11):795-6. PubMed ID: 16280960 [No Abstract] [Full Text] [Related]
37. Dimensional analysis of HRV in hypertrophic cardiomyopathy patients. Carvajal R; Zebrowski JJ; Vallverdú M; Baranowski R; Chojnowska L; Poplawska W; Caminal P IEEE Eng Med Biol Mag; 2002; 21(4):71-8. PubMed ID: 12222120 [No Abstract] [Full Text] [Related]
38. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444 [TBL] [Abstract][Full Text] [Related]
39. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy. Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087 [TBL] [Abstract][Full Text] [Related]
40. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]